This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Universitë De Bordeaux, Université´ D'aix-Marseille, Université De Bourgogne. Active years: 2001-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Marseille, FR (2015)
- Marseilles, FR (2001 - 2017)
Company Filing History:




Years Active: 2001-2017
Title: Michel Camplo: Innovator in Nanoparticle Technology
Introduction
Michel Camplo is a notable inventor based in Marseille, France. He has made significant contributions to the field of nanoparticle technology, particularly in the development of methods for preparing functional amphiphilic molecules. With a total of 3 patents, his work focuses on enhancing the delivery of therapeutic agents, especially in the context of cancer treatment.
Latest Patents
One of Camplo's latest patents is titled "Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof." This invention describes a method that enables the encapsulation of therapeutic agents, particularly anti-tumoral agents, for effective transport and vectorization. Another significant patent is "Functional amphiphilic molecule or macromolecule formulations with multiple compartments." This invention introduces novel formulations designed for transporting or targeting therapeutic agents, specifically antitumor agents, along with methods for their preparation and use.
Career Highlights
Throughout his career, Michel Camplo has been associated with prestigious institutions such as Université d'Aix-Marseille and Université de Bordeaux. His work has been instrumental in advancing the understanding and application of nanoparticle technology in medicine.
Collaborations
Camplo has collaborated with notable colleagues, including Philippe Barthelemy and Domenico Ungheri. These partnerships have contributed to the innovative research and development of his patented technologies.
Conclusion
Michel Camplo's contributions to nanoparticle technology and therapeutic agent delivery are noteworthy. His patents reflect a commitment to advancing medical science and improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile